Kepler Capital Reaffirms Their Sell Rating on Alcon (ALC)
Analysts Offer Insights on Materials Companies: Hudbay Minerals (HBM), Lundin Gold (OtherLUGDF) and Contango ORE (CTGO)
Buy Rating Justified by Promising Efficacy and Safety Profile of Olema Pharmaceuticals' Drug Combination in Clinical Studies
Analysts' Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM) and PAVmed (PAVM)
Buy Rating Affirmed for Radcom Amidst Strong Revenue Growth and Promising Market Position
Olema Pharmaceuticals Analyst Ratings
LivePerson Analyst Ratings
Intrusion Analyst Ratings
Tigo Energy Analyst Ratings
IPower Analyst Ratings
Roth MKM Maintains Buy on IPower, Raises Price Target to $1.25
Broadwind Analyst Ratings
Alcon Analyst Ratings
Promising Clinical Trial Results Bolster Buy Rating for Olema Pharmaceuticals
CASI Pharmaceuticals Analyst Ratings
Telsey Advisor Adjusts Price Target on On Holding AG to $40 From $37, Maintains Outperform Rating
SmartRent Analyst Ratings
SunPower Shares Cool Down After Huge Rally; Wolfe Downgrades
Pacific Biosciences Analyst Ratings
Analysts' Top Materials Picks: Hudbay Minerals (HBM), Lithium Americas (Argentina) Corp. (LAAC)